GHB Poisoning and Poisoning Induced by Others

NCT03651778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-12-11

No results posted yet for this study

Summary

Patients with suspected GHB poisoning presenting to Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) or a hospital in Oslo (Oslo University Hospital Ullevål, Diakonhjemmet, Lovisenberg) will be included. Oral fluid and blood tests will be analyzed for recreational drugs. Clinical course will be charted, as well as treatment in the ambulance, emergency outpatient clinic and hospital to find predictors for when hospitalization is required.

In the second part of the study the investigators will analyze urine and blood samples from patients presenting to the Oslo Accident and Emergency Outpatient Clinic (Oslo Legevakt) with suspected substance poisoning induced by others, for toxic agents.

Conditions

  • Drug Toxicity

Sponsors & Collaborators

  • Lovisenberg Diakonale Hospital

    collaborator OTHER
  • Diakonhjemmet Hospital

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Oslo Accident and Emergency Outpatient Clinic

    collaborator UNKNOWN
  • Odd Martin Vallersnes

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2023-11-01
Completion
2023-11-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651778 on ClinicalTrials.gov